Why Moderna, Inc. (MRNA) stock moved
Moderna, Inc. (MRNA) shares climbed 9.9% to $59.17 as of August 8, 2026, a significant gain from the prior close of $53.86. BestStocks flagged the session as a major change for MRNA. No single company-specific catalyst was confirmed during the move window. Below, we break down what changed for MRNA, why it matters for investors, how the stock reacted, and the catalysts on the calendar.
MRNA climbed 9.9% to $59.17
MRNA climbed 9.9% in its latest session, moving from $53.86 to $59.17.
What it means for Moderna, Inc. investors
For Moderna, Inc. investors, the recent signals are mixed, leaving the near-term picture neutral / mixed. On the constructive side: Material positive event; Strong 9.9% price move. Weighing against that: MRNA moved -6.40% from its $57.54 open to a $53.86 close on 2026-08-06; Moderna, Inc. (MRNA) moved -3.01% from $58.00 to $56.26 on 2026-08-05. Wall Street's consensus price target sits at $46.11, implying -22.1% downside from $59.17. BestStocks rates the overall signal quality low (57/100). With earnings roughly 89 days out, the next report is the most likely near-term test of the move.
MRNA price reaction
MRNA last traded at $59.17, up $5.31 (+9.86%) from the previous close of $53.86. The session traded on 0.9× average volume (below avg), so participation was unremarkable. Over the past month the stock has ranged between $53.86 and $76.56, and it currently sits about 23% of the way up that band.
Bullish and bearish analyst opinions on Moderna, Inc. (MRNA)
The consensus analyst price target on Moderna, Inc. (MRNA) is $46.11, 22.1% below the recent $59.17. Over the past 90 days analysts logged 0 upgrades, 6 maintains, and 0 downgrades. Here is how the bullish and bearish cases on MRNA line up.
The bullish case
- The Street's most bullish target is $77.00 (+30.1%).
- Material positive event.
- Strong 9.9% price move.
- Moderna, Inc. (MRNA) moved +7.99% from $54.79 to $59.17 on 2026-08-07.
The bearish case
- The consensus analyst price target of $46.11 sits 22.1% below the recent $59.17, so the average target sees limited room to run.
- The most bearish analyst target is $25.00 (-57.7%).
- MRNA moved -6.40% from its $57.54 open to a $53.86 close on 2026-08-06.
- Moderna, Inc. (MRNA) moved -3.01% from $58.00 to $56.26 on 2026-08-05.
Weighing both sides, BestStocks' composite read of recent signals is roughly balanced, as the bull-versus-bear meter above shows. This is an educational summary of the bull and bear case, not investment advice.
Analyst price targets and ratings are FMP consensus figures as of Aug 8, 2026; other aggregators may differ. High and low targets show the range of estimates, not forecasts.
Previous notable changes for MRNA
Frequently asked questions about MRNA
Why did Moderna, Inc. (MRNA) stock move?
MRNA climbed 9.9% to $59.17. No single company-specific catalyst was confirmed during the move window, and it looks technical.
How much did MRNA stock rise?
MRNA gained 9.86% ($5.31) versus the prior close of $53.86, last trading at $59.17 on 0.9× average volume.
When is Moderna, Inc.'s next earnings date?
MRNA's next earnings report is estimated for 2026-11-05 — about 89 days away.
What is the analyst price target for MRNA?
The consensus analyst price target for MRNA is $46.11, about 22.1% below the current $59.17. Over the past 90 days, analysts recorded 0 upgrades, 6 maintains, and 0 downgrades.
How BestStocks tracks MRNA
This page is generated automatically by BestStocks' change-detection system after its price and volume cleared MRNA-specific materiality thresholds, triggering an evidence check. It draws on 20 tracked change events for MRNA, cross-checked against the data sources listed below. Price, volume, and market-capitalization figures are the live intraday quote as of August 8, 2026 and refresh as new information is detected; for companies with multiple share classes, market-cap figures can differ by data source. Analyst price targets and ratings are FMP consensus. This is an educational summary of what changed and why — not personalized investment advice.
